Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 27, 2023

BUY
$41.75 - $54.5 $12,942 - $16,895
310 Added 6.34%
5,200 $0
Q3 2022

Nov 01, 2022

BUY
$43.76 - $53.42 $24,505 - $29,915
560 Added 12.93%
4,890 $214,000
Q2 2022

Aug 05, 2022

SELL
$46.53 - $55.17 $54,672 - $64,824
-1,175 Reduced 21.34%
4,330 $227,000
Q1 2022

May 06, 2022

SELL
$45.75 - $56.69 $11.4 Million - $14.1 Million
-248,090 Reduced 97.83%
5,505 $285,000
Q4 2021

Jan 31, 2022

SELL
$41.32 - $61.25 $51,650 - $76,562
-1,250 Reduced 0.49%
253,595 $14.8 Million
Q3 2021

Oct 22, 2021

SELL
$39.25 - $50.42 $885,480 - $1.14 Million
-22,560 Reduced 8.13%
254,845 $11 Million
Q2 2021

Jul 23, 2021

BUY
$35.91 - $40.68 $4.22 Million - $4.78 Million
117,450 Added 73.43%
277,405 $10.9 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $153,518 - $173,137
-4,584 Reduced 2.79%
159,955 $5.8 Million
Q4 2020

Jan 22, 2021

BUY
$33.47 - $42.56 $1.1 Million - $1.4 Million
32,845 Added 24.94%
164,539 $6.06 Million
Q3 2020

Oct 14, 2020

SELL
$31.75 - $37.25 $16,033 - $18,811
-505 Reduced 0.38%
131,694 $4.83 Million
Q2 2020

Jul 30, 2020

SELL
$30.12 - $36.54 $30,722 - $37,270
-1,020 Reduced 0.77%
132,199 $4.32 Million
Q1 2020

Apr 22, 2020

BUY
$27.03 - $38.62 $3.09 Million - $4.42 Million
114,485 Added 611.11%
133,219 $4.35 Million
Q4 2019

Jan 30, 2020

BUY
$32.92 - $37.36 $13,168 - $14,944
400 Added 2.18%
18,734 $734,000
Q3 2019

Oct 21, 2019

SELL
$32.49 - $42.13 $865,241 - $1.12 Million
-26,631 Reduced 59.23%
18,334 $659,000
Q2 2019

Jul 23, 2019

BUY
$36.98 - $41.52 $11,093 - $12,456
300 Added 0.67%
44,965 $1.95 Million
Q4 2017

Jan 17, 2018

BUY
$33.26 - $35.29 $665,200 - $705,800
20,000 Added 81.09%
44,665 $1.62 Million
Q3 2017

Nov 06, 2017

BUY
$31.0 - $34.15 $764,615 - $842,309
24,665
24,665 $881,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sicart Associates LLC Portfolio

Follow Sicart Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sicart Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sicart Associates LLC with notifications on news.